Trial Profile
Drug Use Investigation of Jzoloft
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2021
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Anxiety disorders; Depressive disorders
- Focus Adverse reactions
- Sponsors Pfizer
- 01 Feb 2021 This trial was completed in 2011 only and now the recent update in NCT00605865 and NCT00605813 reported that "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.". As per the source "https://investors.pfizer.com/investor-news/press-release-details/2020/Pfizer-Completes-Transaction-to-Combine-Its-Upjohn-Business-with-Mylan/default.aspx, both merged and formed Viatris in Nov 2020. So I am not adding Viatris to associations, as its affiliation for this trial is not clear.
- 11 Oct 2011 Actual trial end date (Sep 2011) added as reported by ClinicalTrials.gov (Parent trial: NCT00605865).
- 11 Oct 2011 Actual trial end date (Sep 2011) added as reported by ClinicalTrials.gov (Parent trial: NCT00605865).